"10.1371_journal.pone.0079901","plos one","2013-11-21T00:00:00Z","Yalai Bai; Huan Cheng; Jennifer Bordeaux; Veronique Neumeister; Sudha Kumar; David L Rimm; David F Stern","Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, United States of America","Conceived and designed the experiments: YB DLR DFS. Performed the experiments: YB JB VN. Analyzed the data: YB HC SK VN. Wrote the paper: YB DLR DFS.","Dr Rimm is a consultant for Genoptix/Novartis, the exclusive licensee to the Yale owned AQUA technology. Dr. Stern is a partial owner of Phosphoproteomics LLC, which holds intellectual property in phosphorylation-based diagnostics, and he receives royalties for sales of antibody PN2A. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","11","Yalai Bai","YB",7,TRUE,3,3,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
